Cargando…

The effect of mutations on binding interactions between the SARS-CoV-2 receptor binding domain and neutralizing antibodies B38 and CB6

SARS-CoV-2 is the pathogen responsible for COVID-19 that has claimed over six million lives as of July 2022. The severity of COVID-19 motivates a need to understand how it could evolve to escape potential treatments and to find ways to strengthen existing treatments. Here, we used the molecular mode...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barnes, Jonathan E., Lund-Andersen, Peik K., Patel, Jagdish Suresh, Ytreberg, F. Marty
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637166/ https://www.ncbi.nlm.nih.gov/pubmed/36335244 http://dx.doi.org/10.1038/s41598-022-23482-5

Ejemplares similares

The Effect of Mutations on Binding Interactions Between the SARS-CoV-2 Receptor Binding Domain and Neutralizing Antibodies
por: Barnes, Jonathan E., et al.
Publicado: (2021)

Defining the HIV Capsid Binding Site of Nucleoporin 153
por: Li, Shunji, et al.
Publicado: (2022)

Fast Calculation of Protein–Protein Binding Free Energies Using Umbrella Sampling with a Coarse-Grained Model
por: Patel, Jagdish Suresh, et al.
Publicado: (2017)

Assessment of software methods for estimating protein-protein relative binding affinities
por: Gonzalez, Tawny R., et al.
Publicado: (2020)

Statistical modeling to quantify the uncertainty of FoldX-predicted protein folding and binding stability
por: Sapozhnikov, Yesol, et al.
Publicado: (2023)

Expanding the watch list for potential Ebola virus antibody escape mutations
por: Patel, Jagdish Suresh, et al.
Publicado: (2019)

Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies
por: Yuan, Meng, et al.
Publicado: (2021)

Predicting the viability of beta-lactamase: How folding and binding free energies correlate with beta-lactamase fitness
por: Yang, Jordan, et al.
Publicado: (2020)

Binding and neutralizing abilities of antibodies towards SARS-CoV-2 S2 domain
por: Gao, Xingsu, et al.
Publicado: (2022)

Predicting the Ability of SARS-CoV-2 to Utilize the ACE2 Receptor for Cell Entry in North American Rodents
por: Lund-Andersen, Peik K., et al.
Publicado: (2021)

Predicting peak spectral sensitivities of vertebrate cone visual pigments using atomistic molecular simulations
por: Patel, Jagdish Suresh, et al.
Publicado: (2018)

Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain
por: Chi, Xiaojing, et al.
Publicado: (2020)

Computational Analysis of Mutations in the Receptor-Binding Domain of SARS-CoV-2 Spike and Their Effects on Antibody Binding
por: Bozdaganyan, Marine E., et al.
Publicado: (2022)

Immunogenicity of SARS-CoV: the Receptor-Binding Domain of S Protein is a Major Target of Neutralizing Antibodies
por: He, Yuxian
Publicado: (2006)

Neutralization of SARS‐CoV‐2 requires antibodies against conformational receptor‐binding domain epitopes
por: Gattinger, Pia, et al.
Publicado: (2021)

A Structural Landscape of Neutralizing Antibodies Against SARS-CoV-2 Receptor Binding Domain
por: Niu, Ling, et al.
Publicado: (2021)

Changing Folding and Binding Stability in a Viral Coat Protein: A Comparison between Substitutions Accessible through Mutation and Those Fixed by Natural Selection
por: Miller, Craig R., et al.
Publicado: (2014)

An antibody-escape calculator for mutations to the SARS-CoV-2 receptor-binding domain
por: Greaney, Allison J., et al.
Publicado: (2021)

An antibody-escape estimator for mutations to the SARS-CoV-2 receptor-binding domain
por: Greaney, Allison J, et al.
Publicado: (2022)

Comprehensive Deep Mutational Scanning Reveals the Immune-Escaping Hotspots of SARS-CoV-2 Receptor-Binding Domain Targeting Neutralizing Antibodies
por: Tsai, Keng-Chang, et al.
Publicado: (2021)

A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape Mutants
por: Haslwanter, Denise, et al.
Publicado: (2021)

A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein
por: Li, Yan, et al.
Publicado: (2015)

A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
por: Chi, Xiangyang, et al.
Publicado: (2020)

A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein
por: Kim, Cheolmin, et al.
Publicado: (2021)

Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2
por: Yu, Fei, et al.
Publicado: (2020)

Deep mutational learning predicts ACE2 binding and antibody escape to combinatorial mutations in the SARS-CoV-2 receptor-binding domain
por: Taft, Joseph M., et al.
Publicado: (2022)

Structural classification of neutralizing antibodies against the SARS-CoV-2 spike receptor-binding domain suggests vaccine and therapeutic strategies
por: Barnes, Christopher O., et al.
Publicado: (2020)

The impact of receptor-binding domain natural mutations on antibody recognition of SARS-CoV-2
por: Li, Cheng, et al.
Publicado: (2021)

Neutralizing antibodies targeting the SARS‐CoV‐2 receptor binding domain isolated from a naïve human antibody library
por: Bell, Benjamin N., et al.
Publicado: (2021)

Attenuated Influenza Virions Expressing the SARS-CoV-2 Receptor-Binding Domain Induce Neutralizing Antibodies in Mice
por: Loes, Andrea N., et al.
Publicado: (2020)

Attenuated influenza virions expressing the SARS-CoV-2 receptor-binding domain induce neutralizing antibodies in mice
por: Loes, Andrea N., et al.
Publicado: (2020)

Binding, Neutralization and Internalization of the Interleukin-13 Antibody, Lebrikizumab
por: Okragly, Angela J., et al.
Publicado: (2023)

Permissive omicron breakthrough infections in individuals with binding or neutralizing antibodies to ancestral SARS-CoV-2
por: Williams, Erin, et al.
Publicado: (2022)

Structural analysis of receptor binding domain mutations in SARS-CoV-2 variants of concern that modulate ACE2 and antibody binding
por: Mannar, Dhiraj, et al.
Publicado: (2021)

Computational approach for binding prediction of SARS-CoV-2 with neutralizing antibodies
por: Beshnova, Daria, et al.
Publicado: (2022)

Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain
por: Yang, Mei, et al.
Publicado: (2021)

Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-neutralizing antibodies for SARS-related viruses
por: Shinnakasu, Ryo, et al.
Publicado: (2021)

Enhancing neutralizing antibodies against receptor binding domain of SARS-CoV-2 by a safe natural adjuvant system
por: Darvish, Maliheh, et al.
Publicado: (2023)

Steered molecular dynamic simulations reveal Marfan syndrome mutations disrupt fibrillin-1 cbEGF domain mechanosensitive calcium binding
por: Haller, Stephen J., et al.
Publicado: (2020)

Structure of Severe Acute Respiratory Syndrome Coronavirus Receptor-binding Domain Complexed with Neutralizing Antibody
por: Prabakaran, Ponraj, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_9fmhq8qr6dthssdn50et7ngcdi